Martin Gallagher's Publications

About Martin Gallagher's Publications

Professorial Fellow

  • Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

    The Lancet Date published:

  • The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

    Journal of the American Society of Nephrology Date published:

  • Hemodialysis Catheter Rewiring vs. Removal and Replacement: Post Hoc Analysis of a National Stepped Wedge Cluster Randomized Trial

    Journal of the American Society of Nephrology Date published:

  • Burden of Haemodialysis Catheter-Related Bloodstream Infections in Australia: A National Data-Linkage Study

    Journal of the American Society of Nephrology Date published:

  • The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

    Kidney International Reports Date published:

  • Impact of Intensity of Continuous Renal Replacement Therapy on Duration of Ventilation in Critically Ill Patients: A Secondary Analysis of the RENAL Trial

    Blood Purification Date published:

  • Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial

    Intensive Care Medicine Date published:

  • A codesigned integrated kidney and diabetes model of care improves patient activation among patients from culturally and linguistically diverse backgrounds

    Health Expectations Date published:

  • Effect of kidney disease on all-cause and cardiovascular mortality in patients undergoing coronary angiography

    Renal Failure Date published:

  • Effect of a multifaceted intervention on the incidence of haemodialysis catheter dysfunction in a national stepped-wedge cluster randomized trial

    Kidney International Reports Date published:

  • Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care

    Unknown Date published:

  • The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

    Unknown Date published:

  • Characterization of Risk Prediction Models for Acute Kidney Injury

    JAMA Network Open Date published:

  • Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

    Kidney Medicine Date published:

  • Multifaceted Quality Improvement Interventions to Prevent Hemodialysis Catheter-Related Bloodstream Infections: A Systematic Review

    American Journal of Kidney Diseases Date published:

  • Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

    The Lancet Date published: